Drug Information
Drug Generic Name | CHLOROQUINE |
Drug Class | DRUGS SUPPRESSIG THE RHEUMATIC DISEASE PROCESS |
Chapter | Musculoskeletal and Joint Diseases |
Indications: active rheumatoid arthritis, systemic lupus erythematosus; malaria. Cautions: renal and hepatic impairment, pregnancy, porphyria, psoriasis, glucose-6-phosphate dehydorgenase deficiency; elderly patients, children; regular ophthalmic examinations required. Contra-indications: pre-existing maculoretinopathy; concurrent therapy with hepatotoxic drugs. Side Effects: gastro-intestinal disturbances, headache, visual disturbances, irreversible retinal damage, corneal opacities, depigmentation or loss of hair, skin reactions that could be severe to mandate discontinuation of treatment; can rarely lead to deafness; neuromyopathy, sensitization and blood disorders such as thrombocytopenia. Dose: administered on expert advice, chloroquine (base) 150mg daily after food. Max. 2.5mg/kg daily. Child, 3mg/kg daily. Note: 200mg of chloroquine sulfate = 250mg chloroquine phosphate = 150mg chloroquine. |
|
Brand Name |
|